Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI face scan could replace your Doctor's checkup?

NCT ID NCT07491978

Knowledge-focused Sponsor: Tarumanagara University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study will test whether a 1-3 minute AI-powered facial scan can accurately measure vital signs like heart rate and blood pressure, as well as estimate blood sugar, cholesterol, and mental health status. Researchers will compare the scan results with standard medical tests in 1,000 adults living in urban areas. The goal is to develop a simple, non-contact screening tool for early health risk detection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult individuals aged 18 years and above residing in urban areas of Jakarta and the greater metropolitan region (Jabodetabek). Participants will be recruited through a multicenter community-based approach, including primary care facilities, community health posts, campuses, and workplace settings. The population is designed to reflect real-world heterogeneity, including variations in age, sex, ethnicity, and skin tone, as well as a spectrum of cardiometabolic conditions such as hypertension, diabetes mellitus, and dyslipidemia. Both healthy individuals and those with existing metabolic risk factors will be included to ensure broad applicability of findings in an urban population setting.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged ≥18 years. 2. Able and willing to provide written informed consent. 3. Able to comply with study procedures, including face scan, physical examination, blood sampling, and questionnaire completion. 4. Clinically stable at the time of assessment. Exclusion Criteria: 1. Facial conditions affecting the region of interest (ROI), such as injury, deformity, or impaired circulation, that may interfere with rPPG signal acquisition. 2. Presence of facial tattoos or coverings that obstruct optical signal detection. 3. Inability to remain still or comply with measurement procedures during data acquisition. 4. Severe medical conditions that preclude safe participation, as judged by the investigator. 5. Incomplete data or withdrawal of consent during the study. \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome anxiety anxiety disorder atherosclerotic cardiovascular disease depressive disorder diabetes mellitus hypertensive disorder metabolic syndrome X Obesity obesity disorder Overweight sleep disorder Tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety ASCVD Cardiometabolic health indicators Cardiometabolic risk factors Depression disorder Diabetes (DM) Hypertension Metabolic syndrome Obesity / overweight Sleep Stress (psychology) Tachycardia Wellness

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.